Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bermejo

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 5, 2019
Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trialCarlos Taxonera, Antonio López-Sanromán, Isabel Vera-Mendoza, et al.
Journal of Crohn'S & Colitis|April 13, 2017
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised TrialAntonio López-Sanromán, Isabel Vera-Mendoza, Eugeni Domènech, et al.
Journal of Crohn'S & Colitis|March 24, 2020
Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA RegistryMargalida Calafat, Míriam Mañosa, Francisco Mesonero, et al.
Gastroenterologia Y Hepatologia|September 12, 2008
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of responseYago González-Lama, Antonio López-San Román, Ignacio Marín-Jiménez, et al.
Journal of Crohn'S & Colitis|March 24, 2017
Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel DiseaseCarlos Taxonera, Ángel Ponferrada, Fernando Bermejo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 20, 2016
Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agentMaría Del Carmen R-Grau, María Chaparro, Francisco Mesonero, et al.
The American Journal of Gastroenterology|September 4, 2007
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patientsJavier P Gisbert, Fernando Bermejo, Manuel Castro-Fernández, et al.
Cancers|February 11, 2023
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry StudyIvan Guerra, Luis Bujanda, Miriam Mañosa, et al.
Journal of Crohn'S & Colitis|July 28, 2018
Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel DiseaseCarlos Taxonera, Ángel Ponferrada, Sabino Riestra, et al.
Inflammatory Bowel Diseases|March 3, 2016
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort StudyIván Guerra, Tamara Pérez-Jeldres, Marisa Iborra, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 5, 2019
Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trialCarlos Taxonera, Antonio López-Sanromán, Isabel Vera-Mendoza, et al.
Journal of Crohn'S & Colitis|April 13, 2017
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised TrialAntonio López-Sanromán, Isabel Vera-Mendoza, Eugeni Domènech, et al.
Journal of Crohn'S & Colitis|March 24, 2020
Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA RegistryMargalida Calafat, Míriam Mañosa, Francisco Mesonero, et al.
Gastroenterologia Y Hepatologia|September 12, 2008
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of responseYago González-Lama, Antonio López-San Román, Ignacio Marín-Jiménez, et al.
Journal of Crohn'S & Colitis|March 24, 2017
Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel DiseaseCarlos Taxonera, Ángel Ponferrada, Fernando Bermejo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 20, 2016
Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agentMaría Del Carmen R-Grau, María Chaparro, Francisco Mesonero, et al.
The American Journal of Gastroenterology|September 4, 2007
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patientsJavier P Gisbert, Fernando Bermejo, Manuel Castro-Fernández, et al.
Cancers|February 11, 2023
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry StudyIvan Guerra, Luis Bujanda, Miriam Mañosa, et al.
Journal of Crohn'S & Colitis|July 28, 2018
Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel DiseaseCarlos Taxonera, Ángel Ponferrada, Sabino Riestra, et al.
Inflammatory Bowel Diseases|March 3, 2016
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort StudyIván Guerra, Tamara Pérez-Jeldres, Marisa Iborra, et al.
Pageof 14